Precigen, Inc.

PGEN·NasdaqGS·Healthcare
Compare
7.66−0.15 (−1.92%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours7.76+0.10 (+1.31%)Oct 12, 5:51 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.81
Open7.77
Day range7.637.87
52-week range3.048.98
Off day high−2.67%
Off 52-week high−14.70%
Volume2.16M
Avg. volume (3M)5.03M
Market cap2.74B
EPS (TTM)-1.04
Forward P/E-34.82
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.92
Shares outstanding358.04M
Short interest24.36% of float
Earnings dateAug 4, 2026
Analyst target13.65
Profit margin−183.98%

Against its peers

Compare in full ›
PGEN AUTL IDYA IMTX LEGN MRVI
Market cap 2.74B 463.12M 3.48B 1.10B 3.46B 2.61B
P/E (TTM) — — — — — —
Forward P/E -34.8 -2.8 -9.0 -3.5 17.0 -70.1
Price/book 62.8 6.2 2.9 2.2 2.8 5.1
Dividend yield — — — — — —
1-year change +143.30% +7.41% +34.89% −26.36% −43.32% +125.45%
Today −1.92% −3.87% −0.14% −2.96% −4.40% −5.11%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Precigen's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Autolus Therapeutics plcAUTL · Biotechnology 463.12M 1.7400 −3.87%
IDEAYA Biosciences, Inc.IDYA · Biotechnology 3.48B 36.06 −0.14%
Immatics N.V.IMTX · Biotechnology 1.10B 7.21 −2.96%
Legend Biotech CorporationLEGN · Biotechnology 3.46B 17.80 −4.40%
Maravai LifeSciences Holdings, Inc.MRVI · Biotechnology 2.61B 7.06 −5.11%
Xencor, Inc.XNCR · Biotechnology 1.86B 25.04 +1.66%
CRISPR Therapeutics AGCRSP · Biotechnology 4.98B 51.55 −3.45%
Beam Therapeutics Inc.BEAM · Biotechnology 2.60B 25.13 −2.22%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Zai Lab LimitedZLAB · Pudong, China 2.76B 24.59 −1.60%
Maravai LifeSciences Holdings, Inc.MRVI · San Diego, CA 2.61B 7.06 −5.11%
Beam Therapeutics Inc.BEAM · Cambridge, MA 2.60B 25.13 −2.22%
Enliven Therapeutics, Inc.ELVN · Boulder, CO 2.99B 40.84 −0.34%
MBX Biosciences, Inc.MBX · Carmel, IN 2.51B 52.02 −2.29%
Arcus Biosciences, Inc.RCUS · Hayward, CA 3.06B 24.34 −0.29%
NewAmsterdam Pharma Company N.V.NAMS · Naarden, Netherlands 2.48B 21.25 −1.51%
Dyne Therapeutics, Inc.DYN · Waltham, MA 2.98B 15.96 −4.09%

Also based in Germantown, Maryland, then elsewhere in Maryland.

Company Mkt cap Price Today
Senseonics Holdings, Inc.SENS · Germantown, MD 488.56M 9.24 +2.90%
Lockheed Martin CorporationLMT · Bethesda, MDOdds 118.14B 511.88 +0.45%
Constellation Energy CorporationCEG · Baltimore, MD 104.13B 293.89 −1.40%
Marriott International, Inc.MAR · Bethesda, MDOdds 96.30B 369.30 +0.93%
Ciena CorporationCIEN · Fulton, MD 57.43B 405.01 −9.95%
United Therapeutics CorporationUTHR · Silver Spring, MD 23.59B 550.10 +0.17%
T. Rowe Price Group, Inc.TROW · Baltimore, MD 22.18B 103.99 −1.11%
IonQ, Inc.IONQ · College Park, MDOdds 14.69B 36.27 −9.07%

The stocks whose daily moves over the past year went most closely with Precigen's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
CRISPR Therapeutics AGCRSP · Correlation 0.34 4.98B 51.55 −3.45%
Celldex Therapeutics, Inc.CLDX · Correlation 0.33 2.31B 29.43 −1.54%
IDEAYA Biosciences, Inc.IDYA · Correlation 0.32 3.48B 36.06 −0.14%
NewAmsterdam Pharma Company N.V.NAMS · Correlation 0.32 2.48B 21.25 −1.51%

What visitors to Precigen's page also look at.

Company Mkt cap Price Today
Replimune Group, Inc.REPL 1.23B 13.07 −2.61%
Taysha Gene Therapies, Inc.TSHA 1.35B 4.1400 −7.80%
CytomX Therapeutics, Inc.CTMX 527.32M 2.4200 −5.84%
Gossamer Bio, Inc.GOSS 56.76M 9.28 −0.32%
Nkarta, Inc.NKTX 155.43M 2.1700 −3.56%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All PGEN news ›
Clinical Trials Arena·Positive

Surrozen secures FDA clearance for SZN-8141 clinical trial

Surrozen intends to dose the first patient in its DUET clinical trial during the fourth quarter of 2026. The US Food and Drug Administration (FDA) has cleared Surrozen’s investigational new drug (IND) application for SZN-8141 to begin…

Mugglehead·Positive

Surrozen gains FDA IND clearance for SZN-8141

Surrozen expects to dose DUET's first patient in Q4; clearance also meets a condition for a US$95.1M financing close around Oct. 20. A study of an experimental injection for diabetic macular edema can begin after Surrozen, Inc. NASDAQSRZN…

Zacks Investment Research·Positive

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks Equity Research October 01, 2026 PGEN Quick QuotePGEN NRIX Quick QuoteNRIX Precigen, Inc. (PGEN Quick QuotePGEN - Free Report) shares soared 6.3% in the last trading session to close at $8.56. The move was backed by solid volume with…

Markets Daily·Positive

Comparing TScan Therapeutics (NASDAQ:TCRX) & Precigen (NASDAQ:PGEN)

Posted by Danessa Lincoln on Oct 1st, 2026 Precigen (NASDAQ:PGEN – Get Free Report) and TScan Therapeutics (NASDAQ:TCRX – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies…

From articles in the 4Search news index.

In the news

9mentions in 30 days
7with it in the headline
Positivesentiment

Mentioned with

Pfizer6Eli Lilly5Astrazeneca4Biogen3Precigen Gains Advantage3U.S. Food and Drug Administration3Acura Pharmaceuticals2Amgen Inc.2

People in the coverage

Precigen8Aaron Kesselheim2Adrian Gottschalk2Alison Chartan2Barbara Fant2Bomi Kim2

Themes

FDA4Gene Therapy3Health3Pharma3Analyst Recommendations2Biopharma2Biotechnology2Cancer2

Most coverage from

  1. tradingview.com2
  2. clinicaltrialsarena.com1
  3. defenseworld.net1
  4. insidermonkey.com1
  5. mugglehead.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.